Today
+2.53%
5 Days
+14.31%
1 Month
+10.13%
6 Months
+35.13%
Year to Date
+158.96%
1 Year
+465.69%
• Lumentum showcased next-generation optical technologies at the European Conference on Optical Communications. • Multiple analysts reinforced constructive outlooks and ambitious multi-year price targets. • The company reported an annual revenue of $3.01B and net profit of $-6.94B.
• Lumentum faced downward pressure and volatility due to profit-taking after a rally. • Regulatory filings revealed insider share sales and institutional position reductions. • The MACD value of 8.422 indicates a current buy signal.
• Short-term profit-taking and supply chain concerns drove Lumentum Holdings downward. • Lumentum reported an annual revenue of $3.01B and net profit of $-6.94B. • Analysts issued Buy ratings with an average price target of $1117.73.
• Lumentum reported revenue more than doubling year-over-year behind record optical component shipments. • The company's MACD indicates a buy signal, while the RSI remains neutral. • Analysts issued Buy ratings with an average price target of $1,117.73.
• Lumentum reported strong quarterly financial performance driven by expanding artificial intelligence infrastructure. • Analysts issued bullish ratings and raised price targets for the optical components manufacturer. • The company posted annual revenue of $3.01 billion and net profit of $-6.94 billion.
• Lumentum shares rebounded as opportunistic dip-buying followed a sector-wide AI networking pullback. • Surging revenue and 800G product shipments drove strong fundamental sentiment for the company. • Technical indicators like the MACD and Williams %R currently suggest buy conditions.


| Shareholders | Proportion |
|---|---|
| Fidelity Management & Research Company LLC | 9.59% |
| BlackRock Institutional Trust Company, N.A. | 8.00% |
| Vanguard Capital Management, LLC | 5.96% |
| Vanguard Portfolio Management, LLC | 4.76% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 61.16% |
| Investment Advisor/Hedge Fund | 27.20% |
| Hedge Fund | 9.32% |
| Research Firm | 6.32% |
Related Instruments